Michael P. Ellenberger
Affiliations: | National Institute on Drug Abuse |
Area:
Dopamine D2-like ReceptorsGoogle:
"Michael Ellenberger"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Joshua A. Maurer | research assistant | Washington University | |
| Amy H. Newman | research assistant | NIH (NIDA) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bonifazi A, Ellenberger M, Farino ZJ, et al. (2024) Development of novel tools for dissection of central versus peripheral dopamine D -like receptor signaling in dysglycemia. Biorxiv : the Preprint Server For Biology |
| Keck TM, Free RB, Day MM, et al. (2019) Dopamine D4 Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy. Journal of Medicinal Chemistry |
| Bonifazi A, Yano H, Ellenberger MP, et al. (2017) Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. Journal of Medicinal Chemistry |
| Kumar V, Moritz AE, Keck TM, et al. (2017) Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R). Journal of Medicinal Chemistry |
| Michino M, Boateng CA, Donthamsetti P, et al. (2016) Towards understanding the structural basis of partial agonism at the dopamine D3 receptor. Journal of Medicinal Chemistry |
| Cao J, Slack RD, Bakare OM, et al. (2016) Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors. Journal of Medicinal Chemistry. 59: 10676-10691 |
| Kumar V, Bonifazi A, Ellenberger MP, et al. (2016) Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. Journal of Medicinal Chemistry |
| Sanchez-Soto M, Bonifazi A, Cai NS, et al. (2016) Evidence for Non-Canonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-like Receptor Agonist. Molecular Pharmacology |